Cite

HARVARD Citation

    Karkada, M. et al. (n.d.). Immunological and polyfunctional T cell profiling following therapy with DPX-Survivac as a predictive tool of vaccine efficacy. Journal for immunotherapy of cancer. p. . [Online]. 
  
Back to record